Goslings should be vaccinated in a timely manner to prevent disease

Gosling plague

Live vaccine immunization against gosling plague: For goslings hatched from breeder geese that have not been immunized with the live gosling plague vaccine, or from breeder geese immunized with the live gosling plague vaccine more than 100 days previously, the live gosling plague vaccine should be administered by subcutaneous injection within 1 to 2 days after hatching. After immunization, the goslings must be raised in isolation for 7 days to prevent disease caused by infection with virulent field virus before immunity develops. Goslings immunized for 7 days have developed immunity and can basically resist infection with virulent virus without becoming ill. Goslings hatched from immunized breeder geese within the effective period have maternal antibodies and do not need live vaccine immunization. This is because maternal antibodies can neutralize the virus in the live vaccine, preventing the live vaccine from producing sufficient immunity and leading to immunization failure.

Immunization with gosling plague antiserum

In areas where gosling plague is not prevalent, susceptible goslings aged 1 to 7 days should each be given a subcutaneous injection of 0.5 ml.

Immunization with inactivated vaccine against goose hemorrhagic necrotic hepatitis

Goslings around 10 days of age should be immunized with the inactivated vaccine, each receiving a subcutaneous injection of 0.5 ml.

Immunization with inactivated vaccine against goose serositis

Goslings aged 7 to 15 days should be immunized with the inactivated vaccine, each receiving a subcutaneous injection of 0.5 ml.

Immunization with inactivated vaccine against goose avian influenza

For goslings hatched from breeder geese that have not been immunized, or from breeder geese whose last immunization was 3 months previously, avian influenza immunization should be carried out first. If there is no outbreak of this disease locally, an oil-emulsion inactivated vaccine can be used at 10 to 15 days of age, each receiving a subcutaneous injection of 0.5 ml; if there is an outbreak locally, an inactivated vaccine should be used at 5 to 7 days of age, each receiving an injection of 0.5 ml. Liu Zhenghua